(Q28165540)

English

Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)

scientific article (publication date: October 2003)

Statements

Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET) (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
Albert W Chan
0 references
1 October 2003
0 references
42
0 references
7
0 references
1188-95
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit